You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Trump on Cancer-Ridden Biden: ‘I Really Don't Feel Sorry for Him'
- 2. Landscape of targets within nucleoside metabolism for the modification of immune responses
- 3. Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
- 4. UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
- 5. ASCO25: Pfizer's Braftovi combo boasts 47% drop in disease progression in mCRC
- 6. Gut bacteria may hold key to unlocking better cancer treatment
- 7. ASCO 2025: Combination of encorafenib and cetuximab with chemotherapy helps some patients with advanced colorectal cancer live longer
- 8. ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer
- 9. Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
- 10. ASCO 2025: Risk of fourteen obesity-related cancers for people with diabetes
Last updated at 11:41 GMT
Hot News Makers
Health/Pharma Companies
-
977630.14
-
247182.24
-
30885.47
-
11067.27
-
9929.17
-
9227.91
-
7423.38
-
6792.62
-
6722.87
-
5002.48
Drugs, Treatments, Trials
-
251647.88
-
37840.85
-
17272.17
-
12237.17
-
9522.91
-
7142.18
-
2246.28
-
1269.55
-
1134.84
-
1057.96
Last updated at 11:10 GMT
